rs897453 — PEMT
PEMT missense variant (Val95Ile) reducing endogenous phosphatidylcholine synthesis and elevating dietary choline requirements, with strongest impact in premenopausal women and during pregnancy
Details
- Gene
- PEMT
- Chromosome
- 17
- Risk allele
- T
- Clinical
- Risk Factor
- Evidence
- Moderate
Population Frequency
Category
Vitamins & Nutrient AbsorptionSee your personal result for PEMT
Upload your DNA data to find out which genotype you carry and what it means for you.
Upload your DNA dataWorks with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.
PEMT Val95Ile — Your Endogenous Choline Factory
Choline11 Choline
An essential nutrient that serves as a building block for cell
membranes (phosphatidylcholine), the neurotransmitter acetylcholine, and
the methyl donor betaine is
called "essential" for a reason: your body cannot make enough of it on its
own. Almost all of it must come from food — unless you're a premenopausal
woman with a working copy of PEMT22 PEMT
Phosphatidylethanolamine
N-methyltransferase, the liver enzyme that converts PE to PC using
methyl groups donated by SAM (S-adenosylmethionine)
doing its job. The PEMT enzyme synthesizes
phosphatidylcholine33 phosphatidylcholine
The most abundant phospholipid in cell membranes
and lipoproteins; it releases free choline when broken down, making PEMT
the only significant route for endogenous choline production (PC)
from phosphatidylethanolamine in the liver, releasing choline in the
process. This is the body's only meaningful endogenous choline synthesis
pathway.
The rs897453 variant (C→T) causes a valine-to-isoleucine substitution at
position 95 of the PEMT protein. While this conservative missense change
may have some direct effect on enzyme activity, the primary clinical signal
from this SNP appears through tight linkage disequilibrium (r²=0.695) with
rs4646343, a nearby variant that disrupts binding of the
estrogen receptor and FOXA144 estrogen receptor and FOXA1
FOXA1 is a pioneer transcription factor
that opens chromatin and allows the estrogen receptor to bind DNA; without
FOXA1, estrogen cannot activate PEMT expression to the PEMT promoter,
preventing hormone-inducible PEMT expression.
The Mechanism
Estrogen dramatically upregulates PEMT expression in the liver. This is why premenopausal women normally have a built-in advantage: their estrogen activates PEMT, allowing them to synthesize enough phosphatidylcholine endogenously to cover a significant portion of their choline needs. Men and postmenopausal women lack this hormonal boost and must obtain virtually all their choline from diet.
When the region spanning rs897453 and rs4646343 carries the risk haplotype,
the estrogen receptor and FOXA1 pioneer factor cannot bind the PEMT
promoter55 cannot bind the PEMT
promoter
Resseguie et al. showed that the risk allele failed to bind
either the estrogen receptor or FOXA1 in chromatin immunoprecipitation
assays. Without this
estrogen-driven induction, premenopausal women lose their endogenous choline
synthesis advantage and their dietary requirements approach those of men
and postmenopausal women. The one-carbon methyl groups that PEMT uses
(from S-adenosylmethionine, the universal methyl donor) are redirected
or unavailable, compounding effects across the methylation network.
The Evidence
The landmark clinical evidence comes from a carefully controlled
choline depletion trial by da Costa et al.66 choline depletion trial by da Costa et al.
da Costa KA et al. Common
genetic polymorphisms affect the human requirement for the nutrient
choline. FASEB J, 2006:
57 healthy adults consumed a low-choline diet until they developed organ
dysfunction or completed 42 days. Carriers of the risk allele in the PEMT
promoter (rs12325817, in strong LD with rs897453) were dramatically more
susceptible — 78% developed organ dysfunction including
hepatic steatosis77 hepatic steatosis
Fatty liver: excess fat accumulation in liver cells,
detectable by liver enzyme elevation and imaging and muscle damage
(odds ratio 25, p=0.002).
Resseguie et al. 201188 Resseguie et al. 2011
Resseguie ME et al. Aberrant estrogen regulation
of PEMT results in choline deficiency-associated liver dysfunction. J Biol
Chem, 2011 directly
demonstrated the molecular mechanism: the risk haplotype prevents
estrogen-receptor binding at the PEMT promoter, abolishing hormone-inducible
PEMT expression and leaving carriers without the normally protective
estrogen-driven choline synthesis.
Fischer et al. 201099 Fischer et al. 2010
Fischer LM et al. Dietary choline requirements of
women: effects of estrogen and genetic variation. Am J Clin Nutr,
2010 confirmed that while most
premenopausal women can tolerate low dietary choline without developing
dysfunction (protected by estrogen-driven PEMT), women carrying PEMT risk
variants lose this protection and require the same dietary choline as men.
A study by Seremak-Mrozikiewicz et al. 20181010 Seremak-Mrozikiewicz et al. 2018
Seremak-Mrozikiewicz A et al.
Importance of polymorphic variants of PEMT gene in the etiology of
intrauterine fetal death. Eur J Obstet Gynecol Reprod Biol,
2018 found rs897453 among
four PEMT polymorphisms studied in a Polish cohort, with other PEMT variants
in the same region significantly associated with intrauterine fetal death,
highlighting the importance of adequate choline during pregnancy.
Practical Actions
The core implication is straightforward: carriers of the T allele — especially premenopausal women and anyone who is pregnant — need to obtain more choline from diet and possibly supplementation because their liver makes less of it endogenously.
Dietary choline is concentrated in egg yolks (147 mg per large egg), beef liver (~418 mg per 3 oz), salmon, and soybeans. The adequate intake is 425 mg/day for women and 550 mg/day for men, but women carrying PEMT risk variants likely need the higher end of the range. During pregnancy, requirements rise to 450 mg/day or higher.
Phosphatidylcholine supplements (from sunflower or soy lecithin) provide a food-form choline that is well-tolerated, or choline bitartrate for a higher-dose option. CDP-choline (citicoline) is another form used for cognitive applications. Betaine (trimethylglycine) is a related methyl donor that can spare choline in one-carbon metabolism.
Because PEMT uses S-adenosylmethionine (SAM) as the methyl donor, adequate folate and B12 status supports the methylation capacity that feeds into PEMT. Carriers of MTHFR variants alongside rs897453 T alleles may face a compounded methylation burden.
Interactions
rs897453 sits in a haplotype block with rs4646343 and rs12325817 in the PEMT gene. The strongest documented gene-nutrient interaction is with estrogen status: the risk allele matters most in premenopausal women (who otherwise benefit from estrogen-driven PEMT induction) and during pregnancy (high choline demand). In men and postmenopausal women, the estrogen interaction is irrelevant, but the base reduction in PEMT activity still means lower endogenous PC synthesis.
PEMT requires SAM as the methyl donor for the three-step PE→PC methylation. Any variant that impairs SAM availability — including MTHFR C677T (rs1801133) or MTRR variants — will reduce the substrate available for PEMT, compounding the effect of rs897453 on net phosphatidylcholine output. Individuals carrying risk variants in both pathways may have particularly elevated choline requirements.
PEMT V175M (rs7946), a separate coding variant in the same gene, showed association with neural tube defect risk in the Mills et al. 2014 study — though the two variants have different functional mechanisms and should be interpreted independently.
Nutrient Interactions
Genotype Interpretations
What each possible genotype means for this variant:
Normal endogenous phosphatidylcholine synthesis
The CC genotype preserves the wild-type valine at position 95 and maintains the haplotype that allows estrogen receptor and FOXA1 binding to the PEMT promoter. Standard choline intake from a varied diet is typically sufficient for this genotype. Premenopausal women with CC have the full hormonal protection: estrogen drives PEMT expression and provides meaningful endogenous phosphatidylcholine synthesis, reducing dietary choline requirements.
One T allele — moderately reduced endogenous choline synthesis
Heterozygotes retain one functional C allele, which confers partial estrogen-driven PEMT induction. However, the reduced PEMT activity means your liver synthesizes less phosphatidylcholine endogenously, shifting more of your choline requirement to dietary sources. The choline depletion trial by da Costa et al. showed that intermediate carriers had more variable responses, with a meaningful subset developing early organ dysfunction on restricted choline diets.
For premenopausal women, the partial loss of estrogen-driven PEMT induction means you should not rely on endogenous synthesis as your primary choline source.
Two T alleles — substantially reduced endogenous phosphatidylcholine synthesis
TT homozygotes have the greatest impairment in endogenous phosphatidylcholine synthesis. The da Costa et al. choline depletion trial showed that PEMT risk allele carriers were dramatically susceptible to organ dysfunction (fatty liver, liver and muscle enzyme elevation) when dietary choline was restricted — an odds ratio of 25 for the promoter risk haplotype strongly linked to this variant.
For premenopausal women, the Resseguie et al. 2011 study is particularly relevant: the risk haplotype prevents estrogen receptor and FOXA1 binding to the PEMT promoter, meaning estrogen cannot induce PEMT expression. Women with TT who are premenopausal do not get the normal hormonal protection against choline deficiency, and their dietary choline requirements are effectively equivalent to those of men.
Adequate phosphatidylcholine synthesis is essential for very-low-density lipoprotein (VLDL) assembly in the liver. Without sufficient PC, the liver cannot export fat efficiently, contributing to hepatic steatosis. This is why choline deficiency specifically causes fatty liver rather than other forms of organ damage.
During pregnancy, choline is critical for fetal brain development: it is required for neural tube closure, neuronal migration, and memory-circuit formation in the hippocampus. TT carriers who are pregnant face both their own elevated needs and the fetal demand.